ASH – 2023 – Poster Presentation 3425
Publications
December 10, 2023
CD33-Deleted Hematopoietic Cells (Trem-Cel) Are Protected from CD33xCD3 Bispecific Antibody Treatment and Produce Significantly Reduced Levels of Inflammatory Cytokines in Preclinical Studies
Discovery Platform
Presented by: Jessica Lisle, PhD – Preclinical and Translational Biology – Vor Bio